Evaluation of system performance and microbial communities of a bioaugmented anaerobic membrane bioreactor treating pharmaceutical wastewater.
In this study, a control anaerobic membrane bioreactor (C-AnMBR) and a bioaugmented anaerobic membrane bioreactor (B-AnMBR) were operated for 210 d to treat pharmaceutical wastewater. Both the bioreactors were fed with the pharmaceutical wastewater containing TCOD of 16,249 ± 714 mg/L and total dissolved solids (TDS) of 29,450 ± 2209 mg/L with an organic loading rate (OLR) of 13.0 ± 0.6 kgCOD/m(3)d. Under steady-state condition, an average total chemical oxygen demand (TCOD) removal efficiency of 46.1 ± 2.9% and 60.3 ± 2.8% was achieved by the C-AnMBR and the B-AnMBR, respectively. The conventional anaerobes in the C-AnMBR cannot tolerate the hypersaline conditions well, resulting in lower TCOD removal efficiency, biogas production and methane yield than the B-AnMBR seeded from the coastal shore. Pyrosequencing analysis indicated that marine bacterial species (Oliephilus sp.) and halophilic bacterial species (Thermohalobacter sp.) were only present in the B-AnMBR; these species could possibly degrade complex and recalcitrant organic matter and withstand hypersaline environments. Two different dominant archaeal communities, genus Methanosaeta (43.4%) and Methanolobus (61.7%), were identified as the dominant methanogens in the C-AnMBR and the B-AnMBR, respectively. The species of genus Methanolobus was reported resistant to penicillin and required sodium and magnesium for growth, which could enable it to thrive in the hypersaline environment.